ALUR
Allurion Technologies Inc.
NYSE · Healthcare · Medical - Devices · US
$1.12
+1.82%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 12.6M | 15.2M | 32.1M | 53.5M | 64.2M |
| Cost of Revenue | 6.0M | 5.7M | 10.6M | 12.0M | 13.5M |
| Gross Profit | 6.6M | 9.6M | 21.5M | 41.5M | 50.7M |
| Operating Expenses | |||||
| R&D Expense | 5.9M | 7.6M | 17.4M | 27.7M | 17.0M |
| SG&A Expense | 27.4M | 32.2M | 54.3M | 92.9M | 65.8M |
| General & Admin Expense | 18.9M | 21.4M | 28.4M | 46.0M | 15.4M |
| Selling & Marketing Expense | 8.5M | 10.8M | 25.9M | 46.9M | 50.4M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 33.2M | 39.7M | 71.7M | 120.6M | 82.7M |
| Cost and Expenses | 39.2M | 45.4M | 82.3M | 132.5M | 96.2M |
| Operating Income (EBIT) | (26.6M) | (30.2M) | (50.2M) | (79.1M) | (32.0M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 1.8M | — | 2.3M | 10.6M | 4.4M |
| Net Interest Income | (1.8M) | — | (2.3M) | (10.6M) | (4.4M) |
| Other Non-Op Income/Expense | (6.7M) | 1.5M | 24.8M | (1.3M) | (5.6M) |
| Non-Operating Income (excl Interest) | 13.8M | (1.5M) | (27.0M) | (9.3M) | 1.2M |
| EBT (Pre-Tax Income) | (33.3M) | (28.7M) | (25.4M) | (80.3M) | (37.6M) |
| Income Tax Expense | 1.0K | 74.0K | 718.0K | 264.0K | 143.0K |
| Bottom Line | |||||
| Net Income | (33.3M) | (28.8M) | (26.1M) | (80.6M) | (37.7M) |
| Earnings from Cont. Ops | (33.3M) | (28.8M) | (26.1M) | (80.6M) | (37.7M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (33.3M) | (28.8M) | (26.1M) | (82.3M) | (40.7M) |
| Per Share | |||||
| Basic EPS | ($56.40) | ($57.15) | ($48.00) | ($890.70) | ($566.25) |
| Diluted EPS | ($56.40) | ($57.15) | ($48.00) | ($890.70) | ($566.25) |
| Revenue Per Share | $14.15 | $30.28 | $214.34 | $563.49 | $894.52 |
| Shares | |||||
| Basic Shares Outstanding | 890041 | 502969 | 149811 | 94885 | 71783 |
| Diluted Shares Outstanding | 890041 | 502969 | 149811 | 94885 | 71783 |
| Profitability Metrics | |||||
| EBITDA | (39.5M) | (27.7M) | (22.2M) | (69.0M) | (32.3M) |
| D&A | 951.0K | 983.0K | 997.0K | 746.0K | 895.0K |
| EBIT | (40.4M) | (28.7M) | (23.2M) | (69.8M) | (33.2M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026